Wells Fargo Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $21
Wells Fargo analyst Stephen Baxter maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $19 to $21.
Last updated: 2026-11-18 20:11:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Lumexa Imaging Holdings, Inc. (LMRI) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $14.07, with a market capitalization of $1.42B and a P/E ratio of 172.78. Over the past 52 weeks, its price has ranged from $6.45 to $19.45. This page covers its latest market performance, valuation, price trends and company information.
$1.42B | |
$14.61 | |
$15.19 | |
$13.91 | |
$14.63 | |
171.61K | |
389.16K | |
172.78 | |
$19.45 | |
$6.45 | |
-- | |
2026-09-30 |
Lumexa Imaging Holdings, Inc. (LMRI) is currently trading at $14.07 as of 2026-11-18 20:09:00, down 4.65% ($0.68) from the previous close of $14.63
During today's regular trading session, LMRI has traded between $13.91 and $15.19, with a trading volume of 171.61K shares. The current price is near the lower end of today's range.
Over the past seven days, Lumexa Imaging Holdings, Inc. (LMRI) moved from $13.97 to $14.07, representing a gain of 0.72% ($0.10).
The stock traded between $13.44 and $16.62 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 414.34 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 58.6%
LMRI is currently trading at $14.07, placing it 58.6% of the way from its 52-week low of $6.45 to its 52-week high of $19.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 4,335 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Lumexa Imaging Holdings, Inc. and LMRI stock.
Wells Fargo analyst Stephen Baxter maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $19 to $21.
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $13 to $17.
Lumexa Imaging announced the opening of three new outpatient imaging centers in North Carolina, South Carolina, and Texas as part of its de novo expansion strategy. The company has added 5 new centers this year and expects to open 8-10 total in 2026, leveraging favorable market demographics and the shift from hospital-based to outpatient imaging services.
Lumexa Imaging announced its 10th joint venture, this time with Advocate Health to expand outpatient imaging services in Illinois. The partnership marks the company's entry into Illinois and reflects its disciplined geographic expansion strategy focused on health system partnerships and capital-efficient growth.
Eligible investors can buy real shares of Lumexa Imaging Holdings, Inc. (LMRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LMRI, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LMRI shares and USD.
LMRI Shares to USD
1.00 LMRI shares = 14.07 USD
Calculations are estimates based on the latest available price and are for reference only.